A drug that can lower the severity and frequency of migraines will not be subsidised, leaving sufferers fuming.
A drug that can lower the severity and frequency of migraines will not be subsidised, leaving sufferers fuming.

Migraine sufferers fuming as drug subsidy knocked back

Migraine sufferers have slammed Australia's medicine subsidy agency for failing to cover the cost of a revolutionary drug they say can give them their life back.

Pharmaceutical giant Novartis has withdrawn latest its bid to gain a subsidy for its migraine prevention drug Aimovig after its first two applications were refused by the Pharmaceutical Benefits Advisory Committee.

The $800 a month drug was set to be considered for a subsidy at the PBAC's November meeting, where approval was forecast to cost the budget $100 million during over the next six years if a subsidy was granted.

With huge demand for migraine treatments the Pharmaceutical Benefits Scheme has placed a cap on subsidies for existing treatments Botox and Emgality, after which the manufacturers meet the cost of providing the medications.

It’s believed that Aimovig can cut the frequency and severity of migraines in half.
It’s believed that Aimovig can cut the frequency and severity of migraines in half.

The first drug of its type that works by blocking a chemical that triggers a migraine attack, Aimovig can cut the frequency and severity of the condition in half.

Migraine Australia's Raphaella Crosby said she respected Novartis' decision to withdraw its Aimovig PBS application, accusing the PBAC of "bullying" drug companies into giving away their drug for free.

MORE NEWS:

HOW THESE SURVIVORS STARED DOWN DEATH AND WON

BABY EVE'S ARTSY PLAYTIME TURNS INTO A LIFELINE

"We just want our lives back, and these drugs can do that," Ms Crosby said.

"To deny us a chance at a normal life, confined to welfare or constantly at risk of losing our jobs, unable to have a productive life, simply because there's too many of us, is cruel and inexplicable.

"It is not clear if the problem is the PBAC dismiss migraine as 'just a headache', or something else, but we are really unhappy about the way we are being treated.

"It is disrespectful to the millions of Australians whose lives are completely sacrificed to this genetic, incurable disorder, and destroys the first glimmer of hope we've ever had.

Novartis had been providing Aimovig free to Australian patients for the past year as it's first two PBAC applications were assessed and rejected.



TOP 10: Granite Belt’s grandest properties

Premium Content TOP 10: Granite Belt’s grandest properties

Thinking about your next career move or simply dreaming about a new lifestye? Start...

Wind farm goes ‘above and beyond’ into next stage

Premium Content Wind farm goes ‘above and beyond’ into next stage

‘It’s exciting’: This billion dollar Karara project gains ground as talks continue.

REPLAY: Palaszczuk v Frecklington in final debate

REPLAY: Palaszczuk v Frecklington in final debate

Annastacia Palaszczuk v Deb Frecklington in final election debate